Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
J. M. Diez, C. Romero, J. Vergara Alert, M. Bello Perez, J. Rodon, J. M. Honrubia, J. Segales, I. Sola, L. Enjuanes, R. Gajardo
This study shows that currently available IVIG products neutralize SARS-CoV-2 and SARS-CoV in cell cultures but not MERS-CoV.
bioRxiv · Jun 19, 2020Immunology